Find information on thousands of medical conditions and prescription drugs.

Methenamine

Methenamine (INN) or hexamine (former BAN) is a chemical compound comprised of methene (methylene) and an amine. It has two very different common uses: as an antibiotic (commonly the hippurate salt, methenamine hippurate), and as a solid fuel tablet used for cooking while camping or hiking. The name hexamine is more common in non-medicinal applications. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
Macrodantin
Maprotiline
Marcaine
Marezine
Marijuana
Marinol
Marplan
Matulane
Maxair
Maxalt
Maxolon
MDMA
Measurin
Mebendazole
Mebendazole
Meclofenoxate
Medrol
Mefenamic acid
Mefloquine
Melagatran
Melarsoprol
Meloxicam
Melphalan
Memantine
Metadate
Metamfetamine
Metamizole sodium
Metandienone
Metaxalone
Metenolone
Metformin
Methadone
Methamphetamine
Methaqualone
Metharbital
Methcathinone
Methenamine
Methionine
Methocarbamol
Methohexital
Methotrexate
Methotrexate
Methoxsalen
Methylcellulose
Methyldopa
Methylergometrine
Methylin
Methylphenidate
Methylphenobarbital
Methylprednisolone
Methyltestosterone
Methysergide
Metiamide
Metoclopramide
Metohexal
Metoprolol
Metrogel
Metronidazole
Metyrapone
Mobic
Moclobemide
Modafinil
Modicon
Monopril
Montelukast
Motrin
Moxidectin
Moxifloxacin
Moxonidine
MS Contin
Mucinex
Mucomyst
Mupirocin
Mupirocin
Muse
Mycitracin
Mycostatin
Myfortic
Mykacet
Mykinac
Myleran
Mylotarg
Mysoline
Phentermine
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Medicinal use

Methenamine hippurate is mainly used for the prophylaxis (prevention) of urinary tract infections, where it is hydrolysed in the acidic pH of the urine to form formaldehyde. Formaldehyde is an effective antiseptic against bacteria and fungi in vitro, but may not be effective in vivo - it has not shown to be effective for the treatment of urinary tract infections. Furthermore, certain bacteria (including Proteus spp. and Pseudomonas spp. increase urinary pH, rendering methenamine ineffective. (Rossi, 2004)

Methenamine can also be used to treat hyperhidrosis when applied topically. (Beers & Berkow, 1999)

Industrial use

Another important area for use of hexamine is in the production of powdery or liquid preparations of phenolic resins and phenolic resin moulding compounds, where hexamine is added as a hardening component. These products are used as binders, e.g. in brake and clutch linings, abrasive products, non-woven textiles, formed parts produced by moulding processes, and fireproof materials.

Hexamine is also used in corrosion inhibition, as a photochemical, in paints and lacquers, and food preservation. (Roempp, 1997; Ullmann, 1995)

Read more at Wikipedia.org


[List your site here Free!]


Xanthogranulomatous sialadenitis: a case report and literature review
From Ear, Nose & Throat Journal, 6/1/05 by Amy E. Cocco

Abstract

Xanthogranulomatous tissue reaction is an uncommon but well-documented process that occurs at many sites in the body. It is most often recognized in the kidney and gallbladder, where its etiology is believed to involve an outflow obstruction. We report the case of a man with a parotid mass that exhibited features consistent with an inflammatory process on fine-needle aspiration biopsy. The mass persisted despite medical management, and the patient subsequently underwent a superficial parotidectomy. Histologic examination of the resected specimen identified a xanthogranulomatous tissue reaction adjacent to a Warthin's tumor. We compare the features of this case with those of the 2 previously reported cases of xanthogranulomatous sialadenitis, and we discuss its possible etiologies.

Introduction

Xanthogranulomatous tissue reaction is most common in the kidney, where it is believed to develop in the setting of a suppurative infection with renal outflow obstruction. Its involvement in the kidney can occur in a diffuse, focal, or segmental distribution, and sometimes it presents as a mass mimicking a malignancy. Xanthogranulomatous reactions have been described less often at other sites, including the ovary, (1) fallopian tube, (1) endometrium, (1) testicle, (2) appendix, (3) gallbladder, (4) bladder, (5) pituitary gland, (6) colon, (7) prostate, (8) retroperitoneum, (9) and adrenal gland. (10)

In this article, we describe the clinicopathologic findings in a case of xanthogranulomatous sialadenitis that involved the parotid gland in the setting of a Warthin's tumor, and we compare it with the 2 previously reported cases (11-13) of xanthogranulomatous sialadenitis (1 case (11,12) was reported twice).

Case report

A 61-year-old man presented with systemic symptoms of gastric Hodgkin's lymphoma and a right parotid mass. Following treatment of the lymphoma, we addressed the parotid mass, which had become larger and more painful. The parotid symptoms initially resolved with antibiotic treatment, but they returned after treatment was stopped. A subsequent course of antibiotic therapy was initiated, but the symptoms were reffactory to treatment. On fine-needle aspiration biopsy (FNAB), the mass exhibited features consistent with an inflammatory process.

Two months later (1 year after his initial presentation), the patient underwent a superficial parotidectomy. Intraoperatively, a small portion of the mass was sent to pathology for analysis and consultation. Frozen-section analysis identified a proliferation of spindle cells and associated inflammation. Based on these findings, a diagnosis of a reactive/inflammatory process was favored. The entire resected specimen measured 7 x 3 x 3 cm. The mass contained a cystic cavity that was filled with a thick brown fluid. A small portion of tan, finely lobulated salivary gland was identified adjacent to the cavity. The remainder of the tissue was tan-yellow, nodular, and friable.

Histologic analysis identified a xanthogranulomatous tissue reaction characterized by fibroblastic proliferation with mixed inflammatory cells, including abundant foamy macrophages, neutrophils, plasma cells, and lymphocytes (figure). Adjacent to the inflammatory process was a Warthin's tumor.

[FIGURE OMITTED]

Imnunohistochemical stains for macrophages (CD68) and epithelial cells (cytokeratin CAM 5.2 and cytokeratin AE1/AE3) were performed on the formalin-fixed, paraffin-embedded tissue according to the streptavidin-biotinperoxidase method. The results of these stains in the area of fibroblastic proliferation confirmed the presence of abundant macrophages and the absence of epithelial cells. Grocott methenamine-silver and acid-fast stains were negative for fungal and mycobacterial organisms, respectively.

At 2 years of clinical follow-up, the patient's Hodgkin's lymphoma was in complete remission and he exhibited no evidence of residual or recurrent xanthogranulomatous sialadenitis or Warthin's tumor.

Discussion

Xanthogranulomatous reaction in the kidney is a well-documented complication of suppurative renal infection. The mechanism is believed to be associated with renal outflow obstruction in the face of pyogenic infection. It can present as a localized mass lesion or in a diffuse form that obliterates renal parenchyma. In either case, it mimics renal malignancy.

Xanthogranulomatous tissue reaction has been reported at many other sites, (1-10) but the cause in these cases has not been well characterized, probably because of the relatively small number of cases that have been reported. Inflammation and obstruction are frequently cited as common factors in the development of the xanthogranulomatous reaction. A review of 40 cases of xanthogranulomatous cholecystitis suggests that the process in the gallbladder stems from an obstruction of the Rokitansky-Aschoff sinuses by inspissated bile followed by subsequent rupture and a xanthogranulomatous reaction. (4) Xanthogranulomatous appendicitis is usually an incidental finding in patients with chronic inflammation and obstruction by fecalith. (3)

In our case, the histologic and immunohistochemical findings were those of a xanthogranulomatous tissue reaction adjacent to a Warthin's tumor. Out search of the English-language literature revealed only 2 previously reported cases of a xanthogranulomatous reaction involving the parotid gland. (11-13)

All 3 reported cases of xanthogranulomatous sialadenitis have two significant factors in common (table). First, all were associated with a preexisting parotid neoplasm (a Warthin's tumor in 2 cases and a pleomorphic adenoma in the other). Second, all 3 patients underwent FNAB prior to surgical excision. In the case reported by Stephen et al, evidence of a Warthin's tumor was round in the FNAB sample but not in the surgically resected specimen, which contained only the xanthogranulomatous tissue reaction. (13) This suggests that the xanthogranulomatous reaction occurred in response to the FNAB. In our case, the FNAB showed features of an inflammatory process only, suggesting that the development of the xanthogranulomatous reaction preceded the biopsy. The predominant finding in the excised mass obtained from our patient was xanthogranulomatous inflammation, although the mass did contain small areas of residual Warthin's tumor. In the case of the patient who had the preexisting pleomorphic adenoma, there was a long interval (~15 yr) between the resection of the pleomorphic adenoma and the development of the xanthogranulomatous tissue reaction. (11,12)

A comparison of these 3 cases suggests that the development of a xanthogranulomatous tissue reaction in the parotid gland may be the result of a duct obstruction, a mechanism similar to the outflow obstruction implicated in the development of xanthogranulomatous pyelonephritis, cholecystitis, and appendicitis. The duct obstruction in these cases of parotid gland involvement could have been the result of a variety of mechanisms, including a reaction to the FNAB, extravasation of the contents of the Warthin's tumor, infection, or postsurgical scarring.

Xanthogranulomatous sialadenitis can be difficult to diagnose, particularly at the time of frozen-section evaluation. The spindle cell proliferation that accompanies the xanthogranulomatous inflammation could be confused with a mesenchymal neoplasm such as a low-grade sarcoma. In our case, the accompanying inflammatory infiltrate suggested a reactive/inflammatory process. The absence of the Warthin's tumor component in the material submitted for frozen-section analysis further complicated interpretation.

The reporting of additional cases of xanthogranulomatous sialadenitis may help elucidate the mechanism of its development.

References

(1.) Ladefoged C, Lorentzen M. Xanthogranulomatous inflammation of the female genital tract. Histopathology 1988; 13:541-51.

(2.) Hajri M, Amna MB, Derouich A, et ai. [Xanthogranulomatous orchitis: Report of 7 cases]. Ann Urol (Paris) 21101;35:237-9.

(3.) Munichor M, Kerner H, Cohen H, et al. Xanthogranulomatous appendicitis--An incidental finding of localized pathology. Ultrastruct Pathol 2000;24:33-9.

(4.) Goodman ZD, Ishak KG. Xanthogranulomatous cholecystitis. Am J Surg Pathol 1981;5:653-9.

(5.) Tai HL, Chen CC, Yeh KT. Xanthogranulomatous cystitis associated with anaerobic bacterial infection. J Urol 1999;162(3 Pt 1): 795-6.

(6.) Tashiro T, Sano T, Xu B, et al. Spectrum of different types of hypophysitis: A clinicopathologic study of hypophysitis in 31 cases. Endroer Pathol 2002;13:183-95.

(7.) Lo CY, Lorentz TG, Poon CS. Xanthogranulomatous inflammation of the sigmoid colon: A case report. Aust N Z J Surg 1996;66: 643-4.

(8.) Miekos E, Wlodarczyk W, Szram S. Xanthogranulomatous prostatitis. Int Urol Nephrol 1986:18:433-7.

(9.) Sheinfeld A, Rubinow A, Steiner A, et al. Retroperitoneal xanthogranuloma. J Urol 1982; 127:772-4.

(10.) Atiemo HO, Nonaka D, Silverberg SG, et al. Xanthogranulomatous adrenalitis. J Urol 2003;170:177.

(11.) Choyce MQ, Padfield CJ, Mercer NS. Xanthogranulomatous sialadenitis, a benign mimic of malignancy. Br J Plast Surg 1993;46: 624-5.

(12.) Padfield CJ, Choyce MQ, Eveson JW. Xanthogranulomatous sialadenitis. Histopathology 1993;23:488-91.

(13.) Stephen MR, Matalka L Stewart CJ, Mackenzie K. Xanthogranulomatous sialadenitis following diagnosis of Warthin's tumour: A possible complication of fine needle aspiration (FNA). Cytopathology 1999:10:276-9.

From the Department of Pathology (Dr. Cocco, Dr. MacLennan, and Dr. Wasman) and the Department of Otolaryngology (Dr. Lavertu), University Hospitals of Cleveland and Case Western Reserve university.

Reprint requests: Jay K. Wasman, MD, Department of Pathology, University Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44106. Phone: (216) 844-7118; fax: (216) 844-1810; e-mail: jay.wasman@uhhs.com

COPYRIGHT 2005 Medquest Communications, LLC
COPYRIGHT 2005 Gale Group

Return to Methenamine
Home Contact Resources Exchange Links ebay